Skip to main content
. 2020 Dec 9;12(1):88–92. doi: 10.1021/acsmedchemlett.0c00485

Scheme 2. Conversion of Gemcitabine and Its 4′-Substituted Analogues to Their Phosphoramidate Prodrugs.

Scheme 2

Reagents and conditions: (a) DBDC, Na2CO3, dioxane/H2O, 35% for 13a, 23% for 13b, and 59% for 13c; (b) phenyl dichlorophosphate, triethylamine, CH2Cl2, −78 °C, quantitative yield; (c) tert-butylmagnesium chloride, anhydrous THF; (d) trifluoroacetic acid/CH2Cl2, 0 °C, 49% for 16a, 54% for 16b, and 32% for 16c.